Logo image of CLS

CELESTICA INC (CLS) Stock Fundamental Analysis

NYSE:CLS - New York Stock Exchange, Inc. - CA15101Q2071 - Common Stock - Currency: USD

203.7  +1.29 (+0.64%)

Fundamental Rating

6

Taking everything into account, CLS scores 6 out of 10 in our fundamental rating. CLS was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. CLS scores excellent on profitability, but there are some minor concerns on its financial health. CLS is valued quite expensively, but it does show have an excellent growth rating. With these ratings, CLS could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year CLS was profitable.
In the past year CLS had a positive cash flow from operations.
In the past 5 years CLS has always been profitable.
In the past 5 years CLS always reported a positive cash flow from operatings.
CLS Yearly Net Income VS EBIT VS OCF VS FCFCLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

CLS has a better Return On Assets (7.24%) than 87.90% of its industry peers.
With an excellent Return On Equity value of 27.13%, CLS belongs to the best of the industry, outperforming 91.94% of the companies in the same industry.
With an excellent Return On Invested Capital value of 17.26%, CLS belongs to the best of the industry, outperforming 93.55% of the companies in the same industry.
CLS had an Average Return On Invested Capital over the past 3 years of 11.43%. This is above the industry average of 9.27%.
The 3 year average ROIC (11.43%) for CLS is below the current ROIC(17.26%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.24%
ROE 27.13%
ROIC 17.26%
ROA(3y)4.63%
ROA(5y)3.55%
ROE(3y)15.02%
ROE(5y)11.3%
ROIC(3y)11.43%
ROIC(5y)8.93%
CLS Yearly ROA, ROE, ROICCLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of CLS (4.19%) is better than 70.16% of its industry peers.
In the last couple of years the Profit Margin of CLS has grown nicely.
CLS has a Operating Margin of 5.94%. This is in the better half of the industry: CLS outperforms 69.35% of its industry peers.
In the last couple of years the Operating Margin of CLS has grown nicely.
CLS's Gross Margin of 10.76% is on the low side compared to the rest of the industry. CLS is outperformed by 78.23% of its industry peers.
In the last couple of years the Gross Margin of CLS has grown nicely.
Industry RankSector Rank
OM 5.94%
PM (TTM) 4.19%
GM 10.76%
OM growth 3Y24.27%
OM growth 5Y29.03%
PM growth 3Y34%
PM growth 5Y30.13%
GM growth 3Y8.03%
GM growth 5Y10.39%
CLS Yearly Profit, Operating, Gross MarginsCLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLS is creating value.
Compared to 1 year ago, CLS has less shares outstanding
CLS has less shares outstanding than it did 5 years ago.
CLS has a worse debt/assets ratio than last year.
CLS Yearly Shares OutstandingCLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CLS Yearly Total Debt VS Total AssetsCLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

CLS has an Altman-Z score of 5.52. This indicates that CLS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.52, CLS is in the better half of the industry, outperforming 78.23% of the companies in the same industry.
CLS has a debt to FCF ratio of 3.08. This is a good value and a sign of high solvency as CLS would need 3.08 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 3.08, CLS is doing good in the industry, outperforming 68.55% of the companies in the same industry.
A Debt/Equity ratio of 0.59 indicates that CLS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.59, CLS is doing worse than 77.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 3.08
Altman-Z 5.52
ROIC/WACC2.05
WACC8.42%
CLS Yearly LT Debt VS Equity VS FCFCLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

CLS has a Current Ratio of 1.43. This is a normal value and indicates that CLS is financially healthy and should not expect problems in meeting its short term obligations.
CLS has a Current ratio of 1.43. This is in the lower half of the industry: CLS underperforms 77.42% of its industry peers.
A Quick Ratio of 0.85 indicates that CLS may have some problems paying its short term obligations.
CLS has a worse Quick ratio (0.85) than 85.48% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 0.85
CLS Yearly Current Assets VS Current LiabilitesCLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 49.06% over the past year.
The Earnings Per Share has been growing by 48.11% on average over the past years. This is a very strong growth
Looking at the last year, CLS shows a very strong growth in Revenue. The Revenue has grown by 21.17%.
CLS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.38% yearly.
EPS 1Y (TTM)49.06%
EPS 3Y44.1%
EPS 5Y48.11%
EPS Q2Q%52.75%
Revenue 1Y (TTM)21.17%
Revenue growth 3Y19.63%
Revenue growth 5Y10.38%
Sales Q2Q%20.97%

3.2 Future

CLS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.42% yearly.
Based on estimates for the next years, CLS will show a quite strong growth in Revenue. The Revenue will grow by 16.45% on average per year.
EPS Next Y23.72%
EPS Next 2Y21.86%
EPS Next 3Y22.07%
EPS Next 5Y24.42%
Revenue Next Year13.73%
Revenue Next 2Y15.69%
Revenue Next 3Y16.45%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLS Yearly Revenue VS EstimatesCLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
CLS Yearly EPS VS EstimatesCLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 42.97, the valuation of CLS can be described as expensive.
CLS's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.61. CLS is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 34.99, the valuation of CLS can be described as expensive.
CLS's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of CLS to the average of the S&P500 Index (37.13), we can say CLS is valued inline with the index average.
Industry RankSector Rank
PE 42.97
Fwd PE 34.99
CLS Price Earnings VS Forward Price EarningsCLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CLS.
The rest of the industry has a similar Price/Free Cash Flow ratio as CLS.
Industry RankSector Rank
P/FCF 76.59
EV/EBITDA 32.13
CLS Per share dataCLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLS does not grow enough to justify the current Price/Earnings ratio.
CLS has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CLS's earnings are expected to grow with 22.07% in the coming years.
PEG (NY)1.81
PEG (5Y)0.89
EPS Next 2Y21.86%
EPS Next 3Y22.07%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CLS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CELESTICA INC

NYSE:CLS (7/31/2025, 11:53:08 AM)

203.7

+1.29 (+0.64%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)07-28 2025-07-28/amc
Earnings (Next)10-21 2025-10-21/amc
Inst Owners76.87%
Inst Owner Change0.96%
Ins Owners0.53%
Ins Owner Change27.81%
Market Cap23.43B
Analysts82.22
Price Target104.38 (-48.76%)
Short Float %3.88%
Short Ratio1.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.3%
Min EPS beat(2)1.95%
Max EPS beat(2)6.65%
EPS beat(4)4
Avg EPS beat(4)7.48%
Min EPS beat(4)1.95%
Max EPS beat(4)10.78%
EPS beat(8)8
Avg EPS beat(8)10.16%
EPS beat(12)12
Avg EPS beat(12)8.62%
EPS beat(16)16
Avg EPS beat(16)9.76%
Revenue beat(2)1
Avg Revenue beat(2)0.87%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)2.5%
Revenue beat(4)3
Avg Revenue beat(4)2.38%
Min Revenue beat(4)-0.75%
Max Revenue beat(4)5.37%
Revenue beat(8)7
Avg Revenue beat(8)2.81%
Revenue beat(12)11
Avg Revenue beat(12)3.1%
Revenue beat(16)13
Avg Revenue beat(16)2.59%
PT rev (1m)3.73%
PT rev (3m)-3.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.27%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.24%
Valuation
Industry RankSector Rank
PE 42.97
Fwd PE 34.99
P/S 2.32
P/FCF 76.59
P/OCF 49.52
P/B 15.05
P/tB 25.5
EV/EBITDA 32.13
EPS(TTM)4.74
EY2.33%
EPS(NY)5.82
Fwd EY2.86%
FCF(TTM)2.66
FCFY1.31%
OCF(TTM)4.11
OCFY2.02%
SpS87.69
BVpS13.54
TBVpS7.99
PEG (NY)1.81
PEG (5Y)0.89
Profitability
Industry RankSector Rank
ROA 7.24%
ROE 27.13%
ROCE 21.53%
ROIC 17.26%
ROICexc 19.37%
ROICexgc 26.09%
OM 5.94%
PM (TTM) 4.19%
GM 10.76%
FCFM 3.03%
ROA(3y)4.63%
ROA(5y)3.55%
ROE(3y)15.02%
ROE(5y)11.3%
ROIC(3y)11.43%
ROIC(5y)8.93%
ROICexc(3y)13.32%
ROICexc(5y)10.55%
ROICexgc(3y)18.44%
ROICexgc(5y)14.81%
ROCE(3y)14.26%
ROCE(5y)11.14%
ROICexcg growth 3Y31.4%
ROICexcg growth 5Y28.76%
ROICexc growth 3Y37.65%
ROICexc growth 5Y29.81%
OM growth 3Y24.27%
OM growth 5Y29.03%
PM growth 3Y34%
PM growth 5Y30.13%
GM growth 3Y8.03%
GM growth 5Y10.39%
F-Score8
Asset Turnover1.73
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 3.08
Debt/EBITDA 1.23
Cap/Depr 114.76%
Cap/Sales 1.66%
Interest Coverage 11.11
Cash Conversion 63.55%
Profit Quality 72.42%
Current Ratio 1.43
Quick Ratio 0.85
Altman-Z 5.52
F-Score8
WACC8.42%
ROIC/WACC2.05
Cap/Depr(3y)94.48%
Cap/Depr(5y)73.42%
Cap/Sales(3y)1.62%
Cap/Sales(5y)1.34%
Profit Quality(3y)94.3%
Profit Quality(5y)151.44%
High Growth Momentum
Growth
EPS 1Y (TTM)49.06%
EPS 3Y44.1%
EPS 5Y48.11%
EPS Q2Q%52.75%
EPS Next Y23.72%
EPS Next 2Y21.86%
EPS Next 3Y22.07%
EPS Next 5Y24.42%
Revenue 1Y (TTM)21.17%
Revenue growth 3Y19.63%
Revenue growth 5Y10.38%
Sales Q2Q%20.97%
Revenue Next Year13.73%
Revenue Next 2Y15.69%
Revenue Next 3Y16.45%
Revenue Next 5YN/A
EBIT growth 1Y32.3%
EBIT growth 3Y48.65%
EBIT growth 5Y42.42%
EBIT Next Year45.93%
EBIT Next 3Y22.4%
EBIT Next 5YN/A
FCF growth 1Y46.22%
FCF growth 3Y20.17%
FCF growth 5Y2.76%
OCF growth 1Y41.27%
OCF growth 3Y27.84%
OCF growth 5Y6.55%